Saturday, July 11, 2026

Drug profile · INN

tegafur-gimeracil-oteracil

tegafur-gimeracil-oteracil is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — tegafur-gimeracil-oteracil
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

tegafur-gimeracil-oteracil is an FDA-listed pharmaceutical active ingredient.

Key facts

INN tegafur-gimeracil-oteracil

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. ENCITJ-GC01 Phase 3 · Eastern Hepatobiliary Surgery · Gastric Cancer
  2. Tegafur-Gimeracil-Oteracil Potassium Phase 3 · Chinese Academy of · Stomach Neoplasm
  3. Tegafur Gimeracil Oteracil Potassium Capsule Phase 2 · Chinese Academy of · Breast Cancer

Frequently asked questions

What is tegafur-gimeracil-oteracil?

tegafur-gimeracil-oteracil is an FDA-listed pharmaceutical active ingredient.